An act to amend Section 11834.23 of the Health and Safety Code, relating to alcohol and drug treatment facilities.
AB 3 would amend California Health and Safety Code Section 11834.23, which currently treats alcohol or other drug recovery or treatment facilities serving six or fewer persons as a residential use of property for local zoning and land-use purposes. Under existing law, those small facilities are generally treated like single-family residences and are shielded from local ordinances that would classify them as boarding houses, institutions, or similar nonresidential uses, while still allowing local governments to apply neutral building, safety, setback, and other generally applicable rules.
The bill creates new exceptions to that residential-use protection for certain facilities licensed on or after January 1, 2026. A facility would lose the residential-use classification if it is within 300 feet of another recovery or treatment facility, shares the same owner or director or shares programs or amenities, and the combined resident count exceeds six. The bill also extends the exception to multiple single-family dwellings used as licensed or unlicensed treatment facilities when they are operated under common ownership or management and are located within 300 feet of one another, and to a single-family dwelling tied by ownership, director, programs, or amenities to a commercially owned, operated, and licensed facility anywhere in the state.
AB 3 would narrow the scope of state preemption over local regulation for certain alcohol and drug recovery or treatment homes by removing the automatic residential-use treatment for specified clustered or affiliated facilities. As a result, some facilities that would otherwise be treated like single-family residences for zoning purposes could become subject to local land-use controls, including possible conditional use permits, zoning variances, or other local approvals, depending on how local ordinances are written and applied. The bill would not change the general protections for small facilities that do not meet the new exception criteria, and it would leave intact local authority over neutral health, safety, building, and environmental standards.
The available record shows no committee transcript, no recorded votes, and no opposition or support statements, so there is no documented debate to gauge sentiment from legislative discussion. Based on the bill text alone, the measure appears aimed at addressing concerns about clustered or functionally linked treatment homes operating under the small-facility residential-use exemption, while preserving the core protections for smaller standalone facilities. The bill had a majority key vote designation, but the absence of recorded committee discussion limits any stronger inference about overall sentiment.
The main point of contention is likely the balance between local zoning control and statewide protection for recovery housing. Supporters of the bill would likely argue that the current law can be used to shield larger, clustered, or affiliated operations from local oversight by splitting residents across nearby homes or using multiple dwellings under common ownership. Opponents would likely argue that the bill could make it harder to site and operate recovery housing, especially for providers using multiple nearby homes or shared services, and could reduce access to treatment and recovery options. The specific triggers in the bill—300-foot proximity, common ownership or director, shared programs or amenities, and the inclusion of unlicensed facilities—suggest the bill is targeted at perceived loopholes rather than at all small treatment homes.